Challenges in the translation and commercialization of cell therapies

Overview of attention for article published in BMC Biotechnology, August 2015

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#14 of 937)
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 3 news outlets
blogs: 1 blog

twitter: 30 X users

Citations

dimensions_citation: 95 Dimensions

Readers on

mendeley: 215 Mendeley

Summary News Blogs X Dimensions citations

So far, Altmetric has seen 3 news stories from 3 outlets.

Bringing biotech to market faster in Montgomery County, Maryland

Business Journals, 28 Apr 2022

In biotechnology, speed matters. Emerging technology has opened a new world of possibilities for treating — and potentially…

Is It Time To Invest In Stem Cell Biotechs?

Seeking Alpha, 03 Jun 2016

Stem cell therapies are a key component of regenerative medicine, a medical field that holds many great promises.

Challenges in the translation and commercialization of cell therapies

Bioportfolio, 08 Aug 2015

BackgroundCell therapies are an emerging form of healthcare that offer significant potential to improve the practice of…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.